Octreoscan radioreceptor imaging

Aart J van der Lely1, Wouter W de Herder, Eric P Krenning

  • 1Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands. vanderlely@inw3.azr.nl

Endocrine
|May 2, 2003
PubMed

Insights

Peptide receptor scintigraphy, using Octreoscan, effectively visualizes somatostatin-receptor-positive tumors. This imaging technique is valuable for staging neuroendocrine tumors and Hodgkin

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiopharmacology

Background:

  • Peptide receptor scintigraphy emerged 15 years ago for in vivo tumor visualization.
  • Octreoscan is a key radiopharmaceutical for imaging somatostatin-receptor-positive tumors.
  • Somatostatin receptor imaging demonstrates high overall sensitivity.

Purpose of the Study:

  • To evaluate the clinical utility of somatostatin receptor imaging.
  • To highlight the role of Octreoscan in tumor localization and staging.

Main Methods:

  • In vivo demonstration of somatostatin-receptor-positive tumors.
  • Utilizing radiolabeled somatostatin analogs.
  • Application of peptide receptor scintigraphy.

Main Results:

  • Octreoscan is clinically important for visualizing somatostatin-receptor-positive tumors.
  • Somatostatin receptor imaging is highly sensitive.
  • Imaging is beneficial for staging neuroendocrine tumors and Hodgkin's disease.

Conclusions:

  • Somatostatin receptor imaging, particularly with Octreoscan, is a valuable tool for specific tumor types.
  • Further studies are needed to establish its role in breast cancer and granulomatous diseases.

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
X-ray Imaging01:24

X-ray Imaging

German physicist Wilhelm Röntgen (1845–1923) was experimenting with electrical current when he discovered that a mysterious and invisible "ray" would pass through his flesh but leave an outline of his bones on a screen coated with a metal compound. In 1895, Röntgen made the first durable record of the internal parts of a living human: an "X-ray" image (as it came to be called) of his wife’s hand. Scientists worldwide quickly began their own experiments with X-rays, and by 1900, X-ray was widely...